REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-01: Form 6-K; Period of report 2026-09-01; Description 6-K; Document zk2636058.htm.
- 2026-08-31: Form 6-K; Period of report 2026-08-31; Description 6-K; Document zk2636045.htm.
- 2026-08-07: Form 6-K; Period of report 2026-08-07; Description 6-K; Document zk2635830.htm.
- 2026-08-06: Form 6-K; Period of report 2026-08-06; Description 6-K; Document zk2635829.htm.